5

Question 1

oxytocin

Answer 1

uterine motility drug

i: induce labor, stimulate last stage of labor, promote postpartum uterine contraction, prevent/tx postpartum uterine atony
ta: uterine contraction in labor
ci: cephalopelvic disproportion, unfavorable fetal position, early preg
c: CAD, HTN, c-section hx, hep/renal impairment
ae: GI, HA/dizzy, HTN, arrhythmia, LT water intoxication, r/t OD (uterus rupture, fetal bradycardia)
di: x
ni: always IV

Question 2

dinoprostone

Answer 2

uterine motility/abortive drug

i: cervical ripening before labor, termination 12-20 week from LMP, evacuate uterine content in missed miscarriage or fetal death
ta: stimulate uterine contraction to abort/evacuate uterine content
ci: >20 week from LMP, various systemic dz, lact
c: HTN, adrenal dz, asthma, acute vaginitis, uterine scarring
ae: HA, N/V/D, abd cramping, heavy uterine bleed, perforate/rupture uterus, diaphoresis, backache, fever/chill
di: x
ni: emotional support, note LMP

Question 3

testosterone

Answer 3

i: HRT, hypogonadism, delayed male puberty, relieve endometriosis, female breast cancer, female fibrocystic breast dz
ta: testosterone-like effect
ci: prostate cancer, male breast cancer, preg/lact / BBW - transdermal - do not touch application site; PO - thromboembolism, hepatitis, liver cancer, fetal abnormality
c: liver dysfx, cardiac dz
ae: CNS, CV, thromboembolism, liver cancer, androgenic effect (hirsutism), antiestrogen effect
di: x
ni: LFT baseline prior and Q6 month, ed admin